Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (141-150 of 179) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|April 27, 2016
A call to reprioritise metrics to evaluate illicit drug policyDan Werb, Michel Kazatchkine, Thomas Kerr, et al.
Neuroscience and Biobehavioral Reviews|April 4, 2025
Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical modelsClaudio Agnorelli, Meg Spriggs, Kate Godfrey, et al.
Consciousness and Cognition|December 11, 2020
The entropic tongue: Disorganization of natural language under LSDCamila Sanz, Carla Pallavicini, Facundo Carrillo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 21, 2013
Cognition in schizophrenia: summary Nice Consultation Meeting 2012David Nutt, Christine C Gispen-de Wied, Celso Arango, et al.
Psychopharmacology|August 8, 2022
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and worldRosalind Watts, Hannes Kettner, Dana Geerts, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 24, 2011
Severity of depression and response to antidepressants: GENPOD randomised controlled trialNicola J Wiles, Jean Mulligan, Tim J Peters, et al.
Trends in Pharmacological Sciences|July 11, 2006
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functionVassilios Papadopoulos, Mario Baraldi, Tomás R Guilarte, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
The International Journal on Drug Policy|February 21, 2018
A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulationOle Rogeberg, Daniel Bergsvik, Lawrence D Phillips, et al.
Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Ranking the harm of non-medically used prescription opioids in the UKJan van Amsterdam, Lawrence Phillips, Graeme Henderson, et al.
Pageof 18

Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|April 27, 2016
A call to reprioritise metrics to evaluate illicit drug policyDan Werb, Michel Kazatchkine, Thomas Kerr, et al.
Neuroscience and Biobehavioral Reviews|April 4, 2025
Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical modelsClaudio Agnorelli, Meg Spriggs, Kate Godfrey, et al.
Consciousness and Cognition|December 11, 2020
The entropic tongue: Disorganization of natural language under LSDCamila Sanz, Carla Pallavicini, Facundo Carrillo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 21, 2013
Cognition in schizophrenia: summary Nice Consultation Meeting 2012David Nutt, Christine C Gispen-de Wied, Celso Arango, et al.
Psychopharmacology|August 8, 2022
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and worldRosalind Watts, Hannes Kettner, Dana Geerts, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 24, 2011
Severity of depression and response to antidepressants: GENPOD randomised controlled trialNicola J Wiles, Jean Mulligan, Tim J Peters, et al.
Trends in Pharmacological Sciences|July 11, 2006
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functionVassilios Papadopoulos, Mario Baraldi, Tomás R Guilarte, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
The International Journal on Drug Policy|February 21, 2018
A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulationOle Rogeberg, Daniel Bergsvik, Lawrence D Phillips, et al.
Regulatory Toxicology and Pharmacology : RTP|September 19, 2015
Ranking the harm of non-medically used prescription opioids in the UKJan van Amsterdam, Lawrence Phillips, Graeme Henderson, et al.
Pageof 18